These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15534078)

  • 1. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice.
    Xie Z; Singh M; Singh K
    Hypertension; 2004 Dec; 44(6):826-31. PubMed ID: 15534078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
    Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
    Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.
    Krishnamurthy P; Subramanian V; Singh M; Singh K
    Hypertension; 2007 Apr; 49(4):865-72. PubMed ID: 17283249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
    Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
    Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice.
    Subramanian V; Krishnamurthy P; Singh K; Singh M
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H673-83. PubMed ID: 16980342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
    Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: role in β-adrenergic receptor-stimulated apoptosis.
    Foster CR; Zha Q; Daniel LL; Singh M; Singh K
    Exp Physiol; 2012 Apr; 97(4):506-15. PubMed ID: 22179422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
    Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
    Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.
    De Acetis M; Notte A; Accornero F; Selvetella G; Brancaccio M; Vecchione C; Sbroggiò M; Collino F; Pacchioni B; Lanfranchi G; Aretini A; Ferretti R; Maffei A; Altruda F; Silengo L; Tarone G; Lembo G
    Circ Res; 2005 May; 96(10):1087-94. PubMed ID: 15860758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice.
    Zhao CH; Ma X; Guo HY; Li P; Liu HY
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1151-1158. PubMed ID: 28698147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
    Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
    Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.